

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | low-density lipoprotein particle clearance (GO:0034383) | 9.49954203 |
| 2 | regulation of sequestering of triglyceride (GO:0010889) | 8.34539407 |
| 3 | triglyceride catabolic process (GO:0019433) | 7.84104220 |
| 4 | white fat cell differentiation (GO:0050872) | 7.48052508 |
| 5 | brown fat cell differentiation (GO:0050873) | 7.23545870 |
| 6 | neutral lipid catabolic process (GO:0046461) | 7.00637924 |
| 7 | acylglycerol catabolic process (GO:0046464) | 7.00637924 |
| 8 | valine metabolic process (GO:0006573) | 6.70908704 |
| 9 | biotin metabolic process (GO:0006768) | 6.41032191 |
| 10 | lipid particle organization (GO:0034389) | 5.83380440 |
| 11 | fatty acid transmembrane transport (GO:1902001) | 5.76576036 |
| 12 | regulation of cholesterol storage (GO:0010885) | 5.65618405 |
| 13 | positive regulation of fatty acid oxidation (GO:0046321) | 5.55411558 |
| 14 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 5.54580072 |
| 15 | triglyceride biosynthetic process (GO:0019432) | 5.39474019 |
| 16 | protein heterotrimerization (GO:0070208) | 5.37208760 |
| 17 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 5.30815285 |
| 18 | carnitine shuttle (GO:0006853) | 5.27095957 |
| 19 | glycerolipid catabolic process (GO:0046503) | 5.19037130 |
| 20 | neutral lipid biosynthetic process (GO:0046460) | 5.17264176 |
| 21 | acylglycerol biosynthetic process (GO:0046463) | 5.17264176 |
| 22 | lipid storage (GO:0019915) | 4.77758935 |
| 23 | fatty acid beta-oxidation (GO:0006635) | 4.76124446 |
| 24 | ethanol oxidation (GO:0006069) | 4.69865638 |
| 25 | response to dietary excess (GO:0002021) | 4.52523200 |
| 26 | branched-chain amino acid metabolic process (GO:0009081) | 4.41548043 |
| 27 | polyol transport (GO:0015791) | 4.40611427 |
| 28 | ovulation from ovarian follicle (GO:0001542) | 4.40024696 |
| 29 | regulation of fatty acid oxidation (GO:0046320) | 4.33378718 |
| 30 | negative regulation of protein autophosphorylation (GO:0031953) | 4.26517673 |
| 31 | carnitine transmembrane transport (GO:1902603) | 4.23748972 |
| 32 | branched-chain amino acid catabolic process (GO:0009083) | 4.22340723 |
| 33 | triglyceride metabolic process (GO:0006641) | 4.20954662 |
| 34 | fatty acid oxidation (GO:0019395) | 4.17505361 |
| 35 | regulation of fatty acid beta-oxidation (GO:0031998) | 4.16212875 |
| 36 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 4.14926483 |
| 37 | thioester biosynthetic process (GO:0035384) | 4.12068036 |
| 38 | acyl-CoA biosynthetic process (GO:0071616) | 4.12068036 |
| 39 | positive regulation of cellular response to insulin stimulus (GO:1900078) | 4.10195494 |
| 40 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 4.09622622 |
| 41 | lipid oxidation (GO:0034440) | 4.09443444 |
| 42 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 4.05138898 |
| 43 | fatty-acyl-CoA metabolic process (GO:0035337) | 4.04611357 |
| 44 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 4.03801454 |
| 45 | transcytosis (GO:0045056) | 4.02665604 |
| 46 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 4.01317121 |
| 47 | fatty acid catabolic process (GO:0009062) | 4.00239493 |
| 48 | coenzyme A biosynthetic process (GO:0015937) | 3.98937067 |
| 49 | acylglycerol metabolic process (GO:0006639) | 3.97309197 |
| 50 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 3.95225001 |
| 51 | positive regulation of fatty acid metabolic process (GO:0045923) | 3.95021188 |
| 52 | fatty acid homeostasis (GO:0055089) | 3.94937532 |
| 53 | negative regulation of granulocyte differentiation (GO:0030853) | 3.91572037 |
| 54 | neutral lipid metabolic process (GO:0006638) | 3.91545034 |
| 55 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 3.91073091 |
| 56 | amino-acid betaine transport (GO:0015838) | 3.86887146 |
| 57 | carnitine transport (GO:0015879) | 3.86887146 |
| 58 | negative regulation of phagocytosis (GO:0050765) | 3.80377917 |
| 59 | plasma lipoprotein particle clearance (GO:0034381) | 3.79758953 |
| 60 | negative regulation of lipid storage (GO:0010888) | 3.79359149 |
| 61 | positive regulation of glucose import (GO:0046326) | 3.79148187 |
| 62 | negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804) | 3.78829610 |
| 63 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 3.78151786 |
| 64 | positive regulation of lipid catabolic process (GO:0050996) | 3.76903335 |
| 65 | positive regulation of glomerulus development (GO:0090193) | 3.72781857 |
| 66 | cellular response to lithium ion (GO:0071285) | 3.72703857 |
| 67 | CDP-diacylglycerol metabolic process (GO:0046341) | 3.69764108 |
| 68 | alpha-linolenic acid metabolic process (GO:0036109) | 3.69525259 |
| 69 | positive regulation of lipid storage (GO:0010884) | 3.69016495 |
| 70 | ethanol metabolic process (GO:0006067) | 3.68618813 |
| 71 | growth hormone receptor signaling pathway (GO:0060396) | 3.64097827 |
| 72 | cellular response to epinephrine stimulus (GO:0071872) | 3.59802332 |
| 73 | tricarboxylic acid metabolic process (GO:0072350) | 3.57133024 |
| 74 | acetyl-CoA metabolic process (GO:0006084) | 3.54810415 |
| 75 | regulation of glycogen (starch) synthase activity (GO:2000465) | 3.53095601 |
| 76 | primary alcohol metabolic process (GO:0034308) | 3.51143497 |
| 77 | positive regulation of insulin receptor signaling pathway (GO:0046628) | 3.50510773 |
| 78 | response to phenylpropanoid (GO:0080184) | 3.50287718 |
| 79 | response to epinephrine (GO:0071871) | 3.47586741 |
| 80 | pentose-phosphate shunt (GO:0006098) | 3.44766944 |
| 81 | NADH metabolic process (GO:0006734) | 3.44128275 |
| 82 | intracellular lipid transport (GO:0032365) | 3.43025225 |
| 83 | phospholipid homeostasis (GO:0055091) | 3.41404805 |
| 84 | oxaloacetate metabolic process (GO:0006107) | 3.40304020 |
| 85 | negative regulation of macrophage differentiation (GO:0045650) | 3.40074663 |
| 86 | positive regulation of cholesterol efflux (GO:0010875) | 3.39648868 |
| 87 | NADPH regeneration (GO:0006740) | 3.38251015 |
| 88 | complement activation, alternative pathway (GO:0006957) | 3.36816117 |
| 89 | negative regulation of gluconeogenesis (GO:0045721) | 3.36665453 |
| 90 | cGMP-mediated signaling (GO:0019934) | 3.32906492 |
| 91 | acyl-CoA metabolic process (GO:0006637) | 3.32468262 |
| 92 | thioester metabolic process (GO:0035383) | 3.32468262 |
| 93 | positive regulation of cholesterol transport (GO:0032376) | 3.31004690 |
| 94 | positive regulation of sterol transport (GO:0032373) | 3.31004690 |
| 95 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.30757941 |
| 96 | glycerol metabolic process (GO:0006071) | 3.29790235 |
| 97 | glomerular filtration (GO:0003094) | 3.29701020 |
| 98 | cellular response to growth hormone stimulus (GO:0071378) | 3.27448298 |
| 99 | regulation of lipid storage (GO:0010883) | 3.26146113 |
| 100 | L-serine transport (GO:0015825) | 3.25698657 |
| 101 | CDP-diacylglycerol biosynthetic process (GO:0016024) | 3.25101682 |
| 102 | positive regulation of macrophage derived foam cell differentiation (GO:0010744) | 3.23524711 |
| 103 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 3.23480030 |
| 104 | triglyceride homeostasis (GO:0070328) | 3.22569419 |
| 105 | acylglycerol homeostasis (GO:0055090) | 3.22569419 |
| 106 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.21910418 |
| 107 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.21910418 |
| 108 | negative regulation of DNA biosynthetic process (GO:2000279) | 3.21588945 |
| 109 | retinol metabolic process (GO:0042572) | 3.21040734 |
| 110 | positive regulation of glucose transport (GO:0010828) | 3.19529725 |
| 111 | phosphatidic acid metabolic process (GO:0046473) | 3.19142980 |
| 112 | phosphatidic acid biosynthetic process (GO:0006654) | 3.19142980 |
| 113 | diacylglycerol metabolic process (GO:0046339) | 3.18979072 |
| 114 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.18491568 |
| 115 | negative regulation of metanephros development (GO:0072217) | 3.17674852 |
| 116 | positive regulation of glycolytic process (GO:0045821) | 3.17618311 |
| 117 | cellular response to vitamin (GO:0071295) | 3.14311495 |
| 118 | regulation of triglyceride catabolic process (GO:0010896) | 3.10628681 |
| 119 | long-chain fatty acid transport (GO:0015909) | 3.10133087 |
| 120 | fat cell differentiation (GO:0045444) | 3.09278627 |
| 121 | apoptotic cell clearance (GO:0043277) | 3.08634570 |
| 122 | negative regulation of smooth muscle cell migration (GO:0014912) | 3.06630356 |
| 123 | negative regulation of smooth muscle cell proliferation (GO:0048662) | 3.05370452 |
| 124 | linoleic acid metabolic process (GO:0043651) | 3.03813745 |
| 125 | tricarboxylic acid cycle (GO:0006099) | 3.03771955 |
| 126 | regulation of triglyceride metabolic process (GO:0090207) | 2.96348241 |
| 127 | protein localization to cell surface (GO:0034394) | 2.94818678 |
| 128 | endocrine hormone secretion (GO:0060986) | 2.94444152 |
| 129 | regulation of cholesterol efflux (GO:0010874) | 2.90382518 |
| 130 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.87792384 |
| 131 | regulation of triglyceride biosynthetic process (GO:0010866) | 2.87040340 |
| 132 | regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640) | 2.86961317 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 6.02026052 |
| 2 | CLOCK_20551151_ChIP-Seq_293T_Human | 4.70274902 |
| 3 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.18588542 |
| 4 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.89071389 |
| 5 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.56394045 |
| 6 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 2.52862272 |
| 7 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.28951511 |
| 8 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.28787970 |
| 9 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.27665033 |
| 10 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.24070912 |
| 11 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 2.11237847 |
| 12 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 2.02862810 |
| 13 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 2.01289771 |
| 14 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 14.1508125 |
| 15 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.90979219 |
| 16 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.80852501 |
| 17 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.79829856 |
| 18 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.70414005 |
| 19 | GATA1_22025678_ChIP-Seq_K562_Human | 1.67206770 |
| 20 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.60797631 |
| 21 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.52465905 |
| 22 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.52334241 |
| 23 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.46953977 |
| 24 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.44879396 |
| 25 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.44879396 |
| 26 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.44203012 |
| 27 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.43206125 |
| 28 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.41214448 |
| 29 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.39840520 |
| 30 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.39594578 |
| 31 | CJUN_26792858_Chip-Seq_BT549_Human | 1.38550365 |
| 32 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.36912567 |
| 33 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.34849800 |
| 34 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.34545493 |
| 35 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.31235801 |
| 36 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.28291006 |
| 37 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.27744788 |
| 38 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.22416810 |
| 39 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.20952123 |
| 40 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.17395352 |
| 41 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.10653927 |
| 42 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.10220343 |
| 43 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.07666785 |
| 44 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.06666243 |
| 45 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.01816432 |
| 46 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.01600617 |
| 47 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.01572046 |
| 48 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.00130408 |
| 49 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.99069453 |
| 50 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.98932546 |
| 51 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.98454064 |
| 52 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.98417725 |
| 53 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.98038064 |
| 54 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.98032935 |
| 55 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.97738136 |
| 56 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.97738136 |
| 57 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.96988208 |
| 58 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.96392573 |
| 59 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.96392573 |
| 60 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.94914232 |
| 61 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.94559758 |
| 62 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.94207106 |
| 63 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.93713297 |
| 64 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.91717707 |
| 65 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.91458104 |
| 66 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.91185559 |
| 67 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.90869750 |
| 68 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.90794519 |
| 69 | SA1_22415368_ChIP-Seq_MEFs_Mouse | 0.90702829 |
| 70 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.88793976 |
| 71 | RXR_22108803_ChIP-Seq_LS180_Human | 0.88615562 |
| 72 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.87379972 |
| 73 | GATA1_19941826_ChIP-Seq_K562_Human | 0.85777973 |
| 74 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.85169611 |
| 75 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.83986530 |
| 76 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.83827357 |
| 77 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.82500491 |
| 78 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.82393762 |
| 79 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.81721467 |
| 80 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.81540474 |
| 81 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.81296115 |
| 82 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.81193738 |
| 83 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.80099266 |
| 84 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.80018950 |
| 85 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.80010120 |
| 86 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.79761020 |
| 87 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.79535661 |
| 88 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.78805364 |
| 89 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.77703053 |
| 90 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.77642540 |
| 91 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.77024546 |
| 92 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.76825930 |
| 93 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.76461433 |
| 94 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.76247815 |
| 95 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.76171063 |
| 96 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.75951266 |
| 97 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.75592179 |
| 98 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.75333336 |
| 99 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.75218771 |
| 100 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.74926270 |
| 101 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.74228216 |
| 102 | KDM2B_26808549_Chip-Seq_K562_Human | 0.73780319 |
| 103 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.73006026 |
| 104 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.72740295 |
| 105 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.70139768 |
| 106 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.70051555 |
| 107 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.69880378 |
| 108 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.69666045 |
| 109 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.69443238 |
| 110 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.68531733 |
| 111 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.68347799 |
| 112 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.68264095 |
| 113 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.66447402 |
| 114 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.66378062 |
| 115 | GATA2_19941826_ChIP-Seq_K562_Human | 0.66245624 |
| 116 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.66231549 |
| 117 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.65854514 |
| 118 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.65792601 |
| 119 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.65785717 |
| 120 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.65731521 |
| 121 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.65320276 |
| 122 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.65017844 |
| 123 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.64858746 |
| 124 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.62942341 |
| 125 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.62198892 |
| 126 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.62109390 |
| 127 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.62075207 |
| 128 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.61933940 |
| 129 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.61850670 |
| 130 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 0.61148821 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005670_abnormal_white_adipose | 7.80903263 |
| 2 | MP0008438_abnormal_cutaneous_collagen | 5.33567837 |
| 3 | MP0005666_abnormal_adipose_tissue | 5.29309260 |
| 4 | MP0004130_abnormal_muscle_cell | 4.78919237 |
| 5 | MP0004185_abnormal_adipocyte_glucose | 4.70508389 |
| 6 | MP0005375_adipose_tissue_phenotype | 4.02765168 |
| 7 | MP0005275_abnormal_skin_tensile | 3.47353081 |
| 8 | MP0000013_abnormal_adipose_tissue | 3.36005901 |
| 9 | MP0002837_dystrophic_cardiac_calcinosis | 3.31781721 |
| 10 | MP0002971_abnormal_brown_adipose | 2.97793396 |
| 11 | MP0000003_abnormal_adipose_tissue | 2.95945202 |
| 12 | MP0009115_abnormal_fat_cell | 2.66481686 |
| 13 | MP0002876_abnormal_thyroid_physiology | 2.65933430 |
| 14 | MP0010329_abnormal_lipoprotein_level | 2.48597218 |
| 15 | MP0005334_abnormal_fat_pad | 2.36868924 |
| 16 | MP0004272_abnormal_basement_membrane | 2.32197007 |
| 17 | MP0003191_abnormal_cellular_cholesterol | 2.18099212 |
| 18 | MP0001661_extended_life_span | 2.16686131 |
| 19 | MP0003705_abnormal_hypodermis_morpholog | 2.15582160 |
| 20 | MP0002970_abnormal_white_adipose | 2.02880048 |
| 21 | MP0003011_delayed_dark_adaptation | 1.92961332 |
| 22 | MP0003868_abnormal_feces_composition | 1.78577785 |
| 23 | MP0002118_abnormal_lipid_homeostasis | 1.72671928 |
| 24 | MP0003959_abnormal_lean_body | 1.71383838 |
| 25 | MP0005535_abnormal_body_temperature | 1.67568099 |
| 26 | MP0004782_abnormal_surfactant_physiolog | 1.62750943 |
| 27 | MP0003724_increased_susceptibility_to | 1.59073648 |
| 28 | MP0000751_myopathy | 1.51323061 |
| 29 | MP0003828_pulmonary_edema | 1.44271123 |
| 30 | MP0006138_congestive_heart_failure | 1.43398377 |
| 31 | MP0005448_abnormal_energy_balance | 1.42947468 |
| 32 | MP0003690_abnormal_glial_cell | 1.34508425 |
| 33 | MP0010368_abnormal_lymphatic_system | 1.28338247 |
| 34 | MP0005452_abnormal_adipose_tissue | 1.27156162 |
| 35 | MP0002060_abnormal_skin_morphology | 1.27076985 |
| 36 | MP0008775_abnormal_heart_ventricle | 1.26782653 |
| 37 | MP0003186_abnormal_redox_activity | 1.18895930 |
| 38 | MP0009780_abnormal_chondrocyte_physiolo | 1.18343896 |
| 39 | MP0002166_altered_tumor_susceptibility | 1.16358007 |
| 40 | MP0001881_abnormal_mammary_gland | 1.15632697 |
| 41 | MP0000750_abnormal_muscle_regeneration | 1.15216936 |
| 42 | MP0002139_abnormal_hepatobiliary_system | 1.13851506 |
| 43 | MP0000767_abnormal_smooth_muscle | 1.12922789 |
| 44 | MP0003045_fibrosis | 1.12336979 |
| 45 | MP0002078_abnormal_glucose_homeostasis | 1.09775232 |
| 46 | MP0001544_abnormal_cardiovascular_syste | 1.08821889 |
| 47 | MP0005385_cardiovascular_system_phenoty | 1.08821889 |
| 48 | MP0005620_abnormal_muscle_contractility | 1.08676788 |
| 49 | MP0003566_abnormal_cell_adhesion | 1.08079924 |
| 50 | MP0000609_abnormal_liver_physiology | 1.07493649 |
| 51 | MP0000343_altered_response_to | 1.05961189 |
| 52 | MP0003950_abnormal_plasma_membrane | 1.04473504 |
| 53 | MP0003279_aneurysm | 1.01829168 |
| 54 | MP0005647_abnormal_sex_gland | 1.01740115 |
| 55 | MP0009840_abnormal_foam_cell | 0.99467308 |
| 56 | MP0004087_abnormal_muscle_fiber | 0.98478515 |
| 57 | MP0003646_muscle_fatigue | 0.97777527 |
| 58 | MP0002909_abnormal_adrenal_gland | 0.97480583 |
| 59 | MP0002933_joint_inflammation | 0.97218776 |
| 60 | MP0001958_emphysema | 0.96437087 |
| 61 | MP0005164_abnormal_response_to | 0.95927723 |
| 62 | MP0001501_abnormal_sleep_pattern | 0.94414496 |
| 63 | MP0001727_abnormal_embryo_implantation | 0.92420174 |
| 64 | MP0002006_tumorigenesis | 0.92142648 |
| 65 | MP0002254_reproductive_system_inflammat | 0.90721856 |
| 66 | MP0005503_abnormal_tendon_morphology | 0.90635542 |
| 67 | MP0002108_abnormal_muscle_morphology | 0.90154750 |
| 68 | MP0000759_abnormal_skeletal_muscle | 0.87840519 |
| 69 | MP0004215_abnormal_myocardial_fiber | 0.87192573 |
| 70 | MP0005365_abnormal_bile_salt | 0.86879171 |
| 71 | MP0001879_abnormal_lymphatic_vessel | 0.86545523 |
| 72 | MP0002796_impaired_skin_barrier | 0.83308658 |
| 73 | MP0002295_abnormal_pulmonary_circulatio | 0.82556997 |
| 74 | MP0002972_abnormal_cardiac_muscle | 0.81783690 |
| 75 | MP0005330_cardiomyopathy | 0.81712021 |
| 76 | MP0001756_abnormal_urination | 0.78217100 |
| 77 | MP0003091_abnormal_cell_migration | 0.78003204 |
| 78 | MP0004883_abnormal_blood_vessel | 0.77565792 |
| 79 | MP0003948_abnormal_gas_homeostasis | 0.74894087 |
| 80 | MP0002168_other_aberrant_phenotype | 0.74803996 |
| 81 | MP0008961_abnormal_basal_metabolism | 0.74712245 |
| 82 | MP0002332_abnormal_exercise_endurance | 0.72833903 |
| 83 | MP0003221_abnormal_cardiomyocyte_apopto | 0.72655231 |
| 84 | MP0004147_increased_porphyrin_level | 0.72642889 |
| 85 | MP0005595_abnormal_vascular_smooth | 0.66786943 |
| 86 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.65774292 |
| 87 | MP0003075_altered_response_to | 0.64486752 |
| 88 | MP0000858_altered_metastatic_potential | 0.64481156 |
| 89 | MP0000230_abnormal_systemic_arterial | 0.63839621 |
| 90 | MP0000249_abnormal_blood_vessel | 0.63618273 |
| 91 | MP0003953_abnormal_hormone_level | 0.63324760 |
| 92 | MP0002638_abnormal_pupillary_reflex | 0.63218440 |
| 93 | MP0006036_abnormal_mitochondrial_physio | 0.62007949 |
| 94 | MP0005319_abnormal_enzyme/_coenzyme | 0.61626238 |
| 95 | MP0005058_abnormal_lysosome_morphology | 0.60693532 |
| 96 | MP0010630_abnormal_cardiac_muscle | 0.60585184 |
| 97 | MP0002009_preneoplasia | 0.60051556 |
| 98 | MP0001177_atelectasis | 0.59790839 |
| 99 | MP0004036_abnormal_muscle_relaxation | 0.59277925 |
| 100 | MP0005388_respiratory_system_phenotype | 0.58593317 |
| 101 | MP0002133_abnormal_respiratory_system | 0.58593317 |
| 102 | MP0005409_darkened_coat_color | 0.58357505 |
| 103 | MP0005332_abnormal_amino_acid | 0.58331621 |
| 104 | MP0001851_eye_inflammation | 0.56510786 |
| 105 | MP0001764_abnormal_homeostasis | 0.55878927 |
| 106 | MP0005508_abnormal_skeleton_morphology | 0.55558665 |
| 107 | MP0002998_abnormal_bone_remodeling | 0.55510449 |
| 108 | MP0001614_abnormal_blood_vessel | 0.55475453 |
| 109 | MP0004084_abnormal_cardiac_muscle | 0.55225938 |
| 110 | MP0000749_muscle_degeneration | 0.55177344 |
| 111 | MP0004858_abnormal_nervous_system | 0.55098879 |
| 112 | MP0003448_altered_tumor_morphology | 0.54815263 |
| 113 | MP0002128_abnormal_blood_circulation | 0.54762853 |
| 114 | MP0001533_abnormal_skeleton_physiology | 0.54736041 |
| 115 | MP0005379_endocrine/exocrine_gland_phen | 0.54669312 |
| 116 | MP0003879_abnormal_hair_cell | 0.54057408 |
| 117 | MP0001542_abnormal_bone_strength | 0.53783355 |
| 118 | MP0009643_abnormal_urine_homeostasis | 0.52586012 |
| 119 | MP0005167_abnormal_blood-brain_barrier | 0.51811965 |
| 120 | MP0005369_muscle_phenotype | 0.45449275 |
| 121 | MP0009763_increased_sensitivity_to | 0.45424399 |
| 122 | MP0005076_abnormal_cell_differentiation | 0.45322618 |
| 123 | MP0009672_abnormal_birth_weight | 0.45247558 |
| 124 | MP0002106_abnormal_muscle_physiology | 0.44120737 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Oligomenorrhea (HP:0000876) | 7.96954002 |
| 2 | Acanthosis nigricans (HP:0000956) | 6.83488319 |
| 3 | Hypertriglyceridemia (HP:0002155) | 5.85741225 |
| 4 | Hyperglycinuria (HP:0003108) | 4.89359054 |
| 5 | Insulin-resistant diabetes mellitus (HP:0000831) | 4.32307137 |
| 6 | Ankle contracture (HP:0006466) | 4.27205281 |
| 7 | Difficulty running (HP:0009046) | 4.23610587 |
| 8 | Increased connective tissue (HP:0009025) | 4.22074451 |
| 9 | Complement deficiency (HP:0004431) | 3.99404674 |
| 10 | Abnormality of glycine metabolism (HP:0010895) | 3.89991075 |
| 11 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.89991075 |
| 12 | Type 1 muscle fiber predominance (HP:0003803) | 3.79126572 |
| 13 | Myoglobinuria (HP:0002913) | 3.74178303 |
| 14 | Broad metatarsal (HP:0001783) | 3.71751048 |
| 15 | Long foot (HP:0001833) | 3.64307764 |
| 16 | Bone cyst (HP:0012062) | 3.59254424 |
| 17 | Cerebral aneurysm (HP:0004944) | 3.56281024 |
| 18 | Increased variability in muscle fiber diameter (HP:0003557) | 3.50128556 |
| 19 | Follicular hyperkeratosis (HP:0007502) | 3.44313962 |
| 20 | Premature rupture of membranes (HP:0001788) | 3.40342269 |
| 21 | Reduced subcutaneous adipose tissue (HP:0003758) | 3.40212809 |
| 22 | Pigmentary retinal degeneration (HP:0001146) | 3.35058282 |
| 23 | Insulin resistance (HP:0000855) | 3.30780872 |
| 24 | Aortic dissection (HP:0002647) | 3.27910138 |
| 25 | Spinal rigidity (HP:0003306) | 3.22331137 |
| 26 | Growth hormone excess (HP:0000845) | 3.19271575 |
| 27 | Protrusio acetabuli (HP:0003179) | 3.15342566 |
| 28 | Polycythemia (HP:0001901) | 3.14242499 |
| 29 | Hemorrhage of the eye (HP:0011885) | 3.11353481 |
| 30 | Vertebral compression fractures (HP:0002953) | 3.09880796 |
| 31 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.01845143 |
| 32 | Hydroxyprolinuria (HP:0003080) | 3.01619663 |
| 33 | Abnormality of proline metabolism (HP:0010907) | 3.01619663 |
| 34 | Aortic aneurysm (HP:0004942) | 3.00834952 |
| 35 | Subcapsular cataract (HP:0000523) | 2.97696563 |
| 36 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.96454205 |
| 37 | Muscle fiber splitting (HP:0003555) | 2.95566034 |
| 38 | Increased muscle lipid content (HP:0009058) | 2.94167258 |
| 39 | Hypoglycemic coma (HP:0001325) | 2.92072045 |
| 40 | Rhabdomyolysis (HP:0003201) | 2.89387515 |
| 41 | Hypoalphalipoproteinemia (HP:0003233) | 2.87464450 |
| 42 | Slender build (HP:0001533) | 2.87015100 |
| 43 | Myocardial infarction (HP:0001658) | 2.85553491 |
| 44 | Nausea (HP:0002018) | 2.82074360 |
| 45 | Abnormality of complement system (HP:0005339) | 2.79205864 |
| 46 | Epidermoid cyst (HP:0200040) | 2.79068195 |
| 47 | Ketoacidosis (HP:0001993) | 2.78575828 |
| 48 | Axonal loss (HP:0003447) | 2.77159307 |
| 49 | Lipoatrophy (HP:0100578) | 2.76907797 |
| 50 | Large hands (HP:0001176) | 2.72868204 |
| 51 | Hyperthyroidism (HP:0000836) | 2.72244887 |
| 52 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.66329892 |
| 53 | Multiple enchondromatosis (HP:0005701) | 2.64389860 |
| 54 | Back pain (HP:0003418) | 2.60794256 |
| 55 | Facial shape deformation (HP:0011334) | 2.60674812 |
| 56 | Potter facies (HP:0002009) | 2.60674812 |
| 57 | Facial diplegia (HP:0001349) | 2.58583637 |
| 58 | Lymphangioma (HP:0100764) | 2.56169043 |
| 59 | Ketosis (HP:0001946) | 2.48711524 |
| 60 | Hyporeflexia of lower limbs (HP:0002600) | 2.45155017 |
| 61 | Hyperpituitarism (HP:0010514) | 2.43690511 |
| 62 | Vascular tortuosity (HP:0004948) | 2.42495180 |
| 63 | Thyroid-stimulating hormone excess (HP:0002925) | 2.42471508 |
| 64 | Venous abnormality (HP:0002624) | 2.41354513 |
| 65 | Pulmonary artery stenosis (HP:0004415) | 2.40937015 |
| 66 | Glomerulonephritis (HP:0000099) | 2.39955640 |
| 67 | Skin nodule (HP:0200036) | 2.36226912 |
| 68 | Hyperlipoproteinemia (HP:0010980) | 2.34908318 |
| 69 | Soft skin (HP:0000977) | 2.34754018 |
| 70 | Shallow orbits (HP:0000586) | 2.34401932 |
| 71 | Wormian bones (HP:0002645) | 2.30153671 |
| 72 | Increased serum pyruvate (HP:0003542) | 2.29868005 |
| 73 | Infantile muscular hypotonia (HP:0008947) | 2.29493441 |
| 74 | Accelerated skeletal maturation (HP:0005616) | 2.27651716 |
| 75 | Dicarboxylic aciduria (HP:0003215) | 2.26700181 |
| 76 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.26700181 |
| 77 | Right ventricular cardiomyopathy (HP:0011663) | 2.25949442 |
| 78 | Abnormal cartilage morphology (HP:0002763) | 2.24534449 |
| 79 | Neck muscle weakness (HP:0000467) | 2.21219289 |
| 80 | Prenatal maternal abnormality (HP:0002686) | 2.19558287 |
| 81 | Prominent supraorbital ridges (HP:0000336) | 2.19328273 |
| 82 | Esophageal varix (HP:0002040) | 2.18854475 |
| 83 | Decreased subcutaneous fat (HP:0001002) | 2.17161541 |
| 84 | Hyperglycinemia (HP:0002154) | 2.16808279 |
| 85 | Abnormal hemoglobin (HP:0011902) | 2.16205257 |
| 86 | Tetraparesis (HP:0002273) | 2.15467899 |
| 87 | Interstitial pulmonary disease (HP:0006530) | 2.15139395 |
| 88 | Aneurysm (HP:0002617) | 2.14713101 |
| 89 | Pancreatitis (HP:0001733) | 2.13302301 |
| 90 | Exercise-induced myalgia (HP:0003738) | 2.11106191 |
| 91 | Hyperammonemia (HP:0001987) | 2.10203407 |
| 92 | Enlarged penis (HP:0000040) | 2.08783454 |
| 93 | Cervical subluxation (HP:0003308) | 2.07603000 |
| 94 | Toxemia of pregnancy (HP:0100603) | 2.07455973 |
| 95 | Dilatation of the ascending aorta (HP:0005111) | 2.06909252 |
| 96 | Ileus (HP:0002595) | 2.06019880 |
| 97 | Joint hemorrhage (HP:0005261) | 2.05873007 |
| 98 | Amyloidosis (HP:0011034) | 2.05582225 |
| 99 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.05152479 |
| 100 | Rectal prolapse (HP:0002035) | 2.05062438 |
| 101 | Venous insufficiency (HP:0005293) | 2.03703988 |
| 102 | Mitral valve prolapse (HP:0001634) | 2.02323186 |
| 103 | Muscle stiffness (HP:0003552) | 2.00520151 |
| 104 | Asymmetric septal hypertrophy (HP:0001670) | 2.00421691 |
| 105 | Arterial tortuosity (HP:0005116) | 2.00352834 |
| 106 | Easy fatigability (HP:0003388) | 1.98948178 |
| 107 | Abnormality of glycolysis (HP:0004366) | 1.97426624 |
| 108 | Striae distensae (HP:0001065) | 1.94571507 |
| 109 | Frequent falls (HP:0002359) | 1.93009555 |
| 110 | Testicular atrophy (HP:0000029) | 1.92371006 |
| 111 | Hyperglycemia (HP:0003074) | 1.92355151 |
| 112 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.91010076 |
| 113 | Abnormality of the periventricular white matter (HP:0002518) | 1.90508118 |
| 114 | Abnormality of subcutaneous fat tissue (HP:0001001) | 1.89985067 |
| 115 | Proximal amyotrophy (HP:0007126) | 1.89646392 |
| 116 | Systemic lupus erythematosus (HP:0002725) | 1.89054514 |
| 117 | Xanthomatosis (HP:0000991) | 1.88857332 |
| 118 | Fragile skin (HP:0001030) | 1.88248325 |
| 119 | Myotonia (HP:0002486) | 1.88213192 |
| 120 | Hypoplasia of the iris (HP:0007676) | 1.87347667 |
| 121 | Colitis (HP:0002583) | 1.87316377 |
| 122 | Polar cataract (HP:0010696) | 1.86691871 |
| 123 | Hypercortisolism (HP:0001578) | 1.86153871 |
| 124 | Hypercholesterolemia (HP:0003124) | 1.85052294 |
| 125 | Gastrointestinal dysmotility (HP:0002579) | 1.84361988 |
| 126 | Abnormal eating behavior (HP:0100738) | 1.83228580 |
| 127 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.82417770 |
| 128 | Osteolytic defects of the hand bones (HP:0009699) | 1.82417770 |
| 129 | Cerebral inclusion bodies (HP:0100314) | 1.81995999 |
| 130 | Nephritis (HP:0000123) | 1.81461028 |
| 131 | Polygenic inheritance (HP:0010982) | 1.81394016 |
| 132 | Autoimmune thrombocytopenia (HP:0001973) | 1.79373344 |
| 133 | Ectopia lentis (HP:0001083) | 1.79181610 |
| 134 | Gowers sign (HP:0003391) | 1.77952586 |
| 135 | Fibular hypoplasia (HP:0003038) | 1.77686090 |
| 136 | Deep venous thrombosis (HP:0002625) | 1.72932539 |
| 137 | Stridor (HP:0010307) | 1.70413553 |
| 138 | Blue sclerae (HP:0000592) | 1.69631177 |
| 139 | Pulmonary hypertension (HP:0002092) | 1.69201575 |
| 140 | Wide anterior fontanel (HP:0000260) | 1.67445692 |
| 141 | Increased mean platelet volume (HP:0011877) | 1.67358940 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CAMK1D | 6.22496646 |
| 2 | TRIB3 | 5.35254239 |
| 3 | CAMK1G | 4.56543540 |
| 4 | SIK1 | 4.31369443 |
| 5 | BCKDK | 3.55110257 |
| 6 | PDK3 | 2.90481596 |
| 7 | PDK4 | 2.90481596 |
| 8 | RIPK1 | 2.72865388 |
| 9 | LMTK2 | 2.65777531 |
| 10 | ERN1 | 2.24325956 |
| 11 | MST1R | 2.06708463 |
| 12 | PDGFRA | 2.02743249 |
| 13 | MYLK | 2.00072485 |
| 14 | TESK1 | 1.93706299 |
| 15 | PRKAA2 | 1.82544966 |
| 16 | PDK2 | 1.79850626 |
| 17 | FRK | 1.65264993 |
| 18 | INSRR | 1.62692276 |
| 19 | FGFR2 | 1.59355051 |
| 20 | TTN | 1.58551378 |
| 21 | FGFR3 | 1.58548270 |
| 22 | CDK9 | 1.53727904 |
| 23 | MAPK4 | 1.50205962 |
| 24 | EPHB2 | 1.48512914 |
| 25 | PRPF4B | 1.41891988 |
| 26 | DDR2 | 1.37678755 |
| 27 | TIE1 | 1.33167416 |
| 28 | PIK3CA | 1.32943192 |
| 29 | NLK | 1.30233033 |
| 30 | TGFBR2 | 1.27056157 |
| 31 | PKN2 | 1.20911974 |
| 32 | CDC42BPA | 1.18935380 |
| 33 | LATS1 | 1.16416826 |
| 34 | CDK6 | 1.11639572 |
| 35 | MAP2K1 | 1.06614521 |
| 36 | PRKD3 | 1.05867863 |
| 37 | TYK2 | 1.05216695 |
| 38 | JAK1 | 1.02742040 |
| 39 | MET | 1.00593638 |
| 40 | PHKG2 | 0.96654228 |
| 41 | PHKG1 | 0.96654228 |
| 42 | PRKAA1 | 0.92311330 |
| 43 | RIPK4 | 0.87701399 |
| 44 | PDGFRB | 0.85453744 |
| 45 | MAP3K13 | 0.85021433 |
| 46 | PAK2 | 0.84846434 |
| 47 | FER | 0.84190769 |
| 48 | FGFR4 | 0.83083607 |
| 49 | DMPK | 0.82163155 |
| 50 | MAPK7 | 0.81598833 |
| 51 | PTK2B | 0.80107592 |
| 52 | PTK2 | 0.79488586 |
| 53 | NEK9 | 0.77710103 |
| 54 | PRKCH | 0.77592114 |
| 55 | LATS2 | 0.75681815 |
| 56 | PDPK1 | 0.75399691 |
| 57 | MAP3K6 | 0.73572077 |
| 58 | ZAP70 | 0.73025205 |
| 59 | STK38 | 0.70217598 |
| 60 | JAK2 | 0.69770296 |
| 61 | GRK5 | 0.69413188 |
| 62 | ILK | 0.68398107 |
| 63 | IRAK3 | 0.65628362 |
| 64 | MTOR | 0.65575134 |
| 65 | RET | 0.64765845 |
| 66 | STK38L | 0.64495402 |
| 67 | MAPK3 | 0.63822903 |
| 68 | MAP3K7 | 0.63090103 |
| 69 | CAMK1 | 0.62658102 |
| 70 | IGF1R | 0.62134958 |
| 71 | PRKD1 | 0.60839458 |
| 72 | MAP3K3 | 0.60725404 |
| 73 | GSK3A | 0.60554055 |
| 74 | FLT3 | 0.59352884 |
| 75 | AKT3 | 0.57843219 |
| 76 | TYRO3 | 0.56782877 |
| 77 | FGFR1 | 0.56539679 |
| 78 | PRKACG | 0.55686843 |
| 79 | MAP3K1 | 0.55202988 |
| 80 | CAMKK2 | 0.54887509 |
| 81 | PDK1 | 0.54526185 |
| 82 | TBK1 | 0.52654819 |
| 83 | SGK3 | 0.52347485 |
| 84 | MOS | 0.51440049 |
| 85 | RPS6KA2 | 0.51411815 |
| 86 | MAPK11 | 0.50677074 |
| 87 | SGK2 | 0.50113958 |
| 88 | INSR | 0.49770776 |
| 89 | BMX | 0.49521328 |
| 90 | JAK3 | 0.49335431 |
| 91 | PRKG1 | 0.48923131 |
| 92 | HIPK2 | 0.46311702 |
| 93 | PAK4 | 0.44994103 |
| 94 | MAP2K3 | 0.44459685 |
| 95 | EPHB1 | 0.44019174 |
| 96 | ADRBK1 | 0.43716244 |
| 97 | KSR2 | 0.43459469 |
| 98 | PRKD2 | 0.42887286 |
| 99 | SGK494 | 0.42309247 |
| 100 | SGK223 | 0.42309247 |
| 101 | YES1 | 0.42175517 |
| 102 | PRKG2 | 0.41791859 |
| 103 | DAPK3 | 0.41711478 |
| 104 | FES | 0.39706298 |
| 105 | MAPK1 | 0.38928884 |
| 106 | MAP2K4 | 0.38772416 |
| 107 | CLK1 | 0.38324978 |
| 108 | PINK1 | 0.38307443 |
| 109 | ABL2 | 0.38203041 |
| 110 | CDK4 | 0.37725561 |
| 111 | MARK2 | 0.37689566 |
| 112 | RPS6KA3 | 0.37136139 |
| 113 | ICK | 0.35860717 |
| 114 | SRC | 0.35833821 |
| 115 | KIT | 0.34746220 |
| 116 | MAPK12 | 0.34412692 |
| 117 | TRPM7 | 0.33230422 |
| 118 | CSK | 0.33207846 |
| 119 | EIF2AK2 | 0.33205427 |
| 120 | EPHA3 | 0.31953660 |
| 121 | RPS6KB1 | 0.30072613 |
| 122 | STK3 | 0.29192212 |
| 123 | ABL1 | 0.27629582 |
| 124 | PTK6 | 0.27482707 |
| 125 | ROCK1 | 0.27421872 |
| 126 | CSF1R | 0.27189641 |
| 127 | DAPK2 | 0.27178810 |
| 128 | KDR | 0.26849092 |
| 129 | MAPKAPK3 | 0.25825013 |
| 130 | IRAK1 | 0.25110809 |
| 131 | TNK2 | 0.23856450 |
| 132 | OBSCN | 0.23351948 |
| 133 | EEF2K | 0.23243951 |
| 134 | AKT1 | 0.20141718 |
| 135 | PIK3CG | 0.19370172 |
| 136 | PAK3 | 0.16875278 |
| 137 | STK11 | 0.16818246 |
| 138 | LRRK2 | 0.15865622 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 4.82416013 |
| 2 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 4.66137479 |
| 3 | PPAR signaling pathway_Homo sapiens_hsa03320 | 4.47901008 |
| 4 | Propanoate metabolism_Homo sapiens_hsa00640 | 4.46600291 |
| 5 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.74597899 |
| 6 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.49588331 |
| 7 | Fatty acid metabolism_Homo sapiens_hsa01212 | 3.48370385 |
| 8 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 3.03049282 |
| 9 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.86952968 |
| 10 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.67714150 |
| 11 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 2.29130804 |
| 12 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.21170089 |
| 13 | AMPK signaling pathway_Homo sapiens_hsa04152 | 2.13136312 |
| 14 | Histidine metabolism_Homo sapiens_hsa00340 | 1.90554587 |
| 15 | Carbon metabolism_Homo sapiens_hsa01200 | 1.70476522 |
| 16 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.68994414 |
| 17 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.64443728 |
| 18 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.63922167 |
| 19 | Insulin resistance_Homo sapiens_hsa04931 | 1.44044202 |
| 20 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.37439211 |
| 21 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.32721128 |
| 22 | Peroxisome_Homo sapiens_hsa04146 | 1.29849902 |
| 23 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.23463840 |
| 24 | * Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.18665531 |
| 25 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.16226577 |
| 26 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.10151418 |
| 27 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.09231004 |
| 28 | Renin secretion_Homo sapiens_hsa04924 | 1.08057596 |
| 29 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.05985727 |
| 30 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 1.05702069 |
| 31 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.02812604 |
| 32 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.02169593 |
| 33 | * Tyrosine metabolism_Homo sapiens_hsa00350 | 1.00564167 |
| 34 | Sulfur relay system_Homo sapiens_hsa04122 | 0.96105007 |
| 35 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.95967479 |
| 36 | Focal adhesion_Homo sapiens_hsa04510 | 0.93643358 |
| 37 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.92686029 |
| 38 | * beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.92188719 |
| 39 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.82722870 |
| 40 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.81093821 |
| 41 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.80634564 |
| 42 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.80352519 |
| 43 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.76850833 |
| 44 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.76352409 |
| 45 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.74096425 |
| 46 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.73154980 |
| 47 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.73131809 |
| 48 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.73078367 |
| 49 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.60730055 |
| 50 | Retinol metabolism_Homo sapiens_hsa00830 | 0.60724577 |
| 51 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.60113698 |
| 52 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.54364157 |
| 53 | ABC transporters_Homo sapiens_hsa02010 | 0.53418879 |
| 54 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.53176198 |
| 55 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.52228096 |
| 56 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.52123848 |
| 57 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.51776599 |
| 58 | Amoebiasis_Homo sapiens_hsa05146 | 0.51762428 |
| 59 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.50201527 |
| 60 | Lysine degradation_Homo sapiens_hsa00310 | 0.50101363 |
| 61 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.49613801 |
| 62 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.47931528 |
| 63 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.46268114 |
| 64 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.45449310 |
| 65 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.45069377 |
| 66 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.45007494 |
| 67 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.44413829 |
| 68 | Pertussis_Homo sapiens_hsa05133 | 0.42879566 |
| 69 | Bile secretion_Homo sapiens_hsa04976 | 0.42792296 |
| 70 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.41459691 |
| 71 | Other glycan degradation_Homo sapiens_hsa00511 | 0.41089584 |
| 72 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.40710211 |
| 73 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.40390564 |
| 74 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.39359429 |
| 75 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.39085364 |
| 76 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.37823933 |
| 77 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.36706903 |
| 78 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.35879621 |
| 79 | Viral myocarditis_Homo sapiens_hsa05416 | 0.35419380 |
| 80 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.33594416 |
| 81 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.33205447 |
| 82 | Melanoma_Homo sapiens_hsa05218 | 0.33066803 |
| 83 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.33004177 |
| 84 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.32951473 |
| 85 | Adherens junction_Homo sapiens_hsa04520 | 0.29841421 |
| 86 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.29234519 |
| 87 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.27939956 |
| 88 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.27040228 |
| 89 | Platelet activation_Homo sapiens_hsa04611 | 0.26451608 |
| 90 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.25689699 |
| 91 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.24802856 |
| 92 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.24274527 |
| 93 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.24187388 |
| 94 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.23931198 |
| 95 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.23271694 |
| 96 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.22916490 |
| 97 | Salivary secretion_Homo sapiens_hsa04970 | 0.22899041 |
| 98 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.20849568 |
| 99 | Malaria_Homo sapiens_hsa05144 | 0.20116193 |
| 100 | Lysosome_Homo sapiens_hsa04142 | 0.19092548 |
| 101 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.18704940 |
| 102 | Thyroid cancer_Homo sapiens_hsa05216 | 0.18218408 |
| 103 | Prion diseases_Homo sapiens_hsa05020 | 0.17387645 |
| 104 | Pathways in cancer_Homo sapiens_hsa05200 | 0.17292242 |
| 105 | Circadian rhythm_Homo sapiens_hsa04710 | 0.17048009 |
| 106 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.16990454 |
| 107 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.16644870 |
| 108 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.16540869 |
| 109 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.16172048 |
| 110 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.15988709 |
| 111 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.15777897 |
| 112 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.15499208 |
| 113 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.15497712 |
| 114 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.14067487 |
| 115 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.14005056 |
| 116 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.13915564 |
| 117 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.13728421 |
| 118 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.13238312 |
| 119 | Glioma_Homo sapiens_hsa05214 | 0.12864745 |
| 120 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.12815988 |
| 121 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.10900154 |
| 122 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.10819948 |
| 123 | Hepatitis C_Homo sapiens_hsa05160 | 0.10793085 |
| 124 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.10677204 |
| 125 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.10320175 |
| 126 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.10046391 |
| 127 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.09981162 |
| 128 | Tight junction_Homo sapiens_hsa04530 | 0.09051141 |
| 129 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.08568411 |
| 130 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.08439250 |
| 131 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.08389028 |

